Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00658294

Enrollment

Registered

2008-04-14

Start date

2008-01-31

Completion date

2012-12-31

Last updated

2017-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Echinococcosis

Brief summary

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles * Trial with medicinal product

Interventions

OTHERStop treatment

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with inoperable alveolar echinococcosis * With negative PET-CT * EmII/3-10 serology under long-term chemotherapy with benzimidazoles

Exclusion criteria

* Positive PET-CT * Positive EmII-3-10 Serology * No compliance * Reduced life expectancy * Pregnancy

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026